Literature DB >> 11955474

Effects of antioxidant, OPC-14117, on secondary cellular damage and behavioral deficits following cortical contusion in the rat.

Naoki Aoyama1, Yoichi Katayama, Tatsuro Kawamata, Takeshi Maeda, Tatsuro Mori, Takamitsu Yamamoto, Tetsuro Kikuchi, Yasuhumi Uwahodo.   

Abstract

In the present study, we examined the effects of OPC-14117, a superoxide radical scavenger, on the secondary cellular damage and cognitive dysfunction occurring in a rat model of cerebral contusion induced by a controlled cortical impact (CCI). Histological examinations revealed that the contusion necrosis volume reached 13.6+/-5.3 mm(3) in non-treated animals and declined to 1.9+/-0.6 mm(3) in OPC-14117-treated animals (P<0.01). The cell number of the CA3 region was 120.0+/-12.4 cells/mm in the normal controls, 73.6+/-9.9 cells/mm in the non-treated animals, and 111.2+/-10.2 cells/mm in the OPC-14117-treated animals, indicating that CCI-induced selective neuronal cell death in the CA3 region was attenuated by the OPC-14117 administration (P<0.01). The tissue osmolality, as determined with a vapor pressure osmometer, was 314.5+/-15.4 mmol/kg in the normal brain and increased to 426.0+/-20.1 mmol/kg at 12 h following CCI. The increase in tissue osmolality was significantly attenuated by OPC-14117 administration (P<0.01). The OPC-14117 administration also attenuated the CCI-induced cognitive deficits. The OPC-14117-treated animals showed a tendency to improve on the Morris water maze performance test. The impairment of the habituation of exploratory activity elicited by CCI was significantly attenuated by OPC-14117 administration (P<0.05). In conclusion, OPC-14117 may have a potential for decreasing secondary cellular damage due to traumatic brain injury since it is as efficacious as any other compound tested in this model.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11955474     DOI: 10.1016/s0006-8993(02)02366-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

1.  The effect of N-acetylcysteine on posttraumatic changes after controlled cortical impact in rats.

Authors:  Ulrich-Wilhelm Thomale; Martin Griebenow; Stefan-Nikolaus Kroppenstedt; Andreas W Unterberg; John F Stover
Journal:  Intensive Care Med       Date:  2005-10-26       Impact factor: 17.440

Review 2.  Drug targets for traumatic brain injury from poly(ADP-ribose)polymerase pathway modulation.

Authors:  Valerie C Besson
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

3.  Necrostatin-1 reduces histopathology and improves functional outcome after controlled cortical impact in mice.

Authors:  Zerong You; Sean I Savitz; Jinsheng Yang; Alexei Degterev; Junying Yuan; Gregory D Cuny; Michael A Moskowitz; Michael J Whalen
Journal:  J Cereb Blood Flow Metab       Date:  2008-05-21       Impact factor: 6.200

Review 4.  Traumatic injury to the immature brain: inflammation, oxidative injury, and iron-mediated damage as potential therapeutic targets.

Authors:  Mathew B Potts; Seong-Eun Koh; William D Whetstone; Breset A Walker; Tomoko Yoneyama; Catherine P Claus; Hovhannes M Manvelyan; Linda J Noble-Haeusslein
Journal:  NeuroRx       Date:  2006-04

Review 5.  Perspectives on molecular biomarkers of oxidative stress and antioxidant strategies in traumatic brain injury.

Authors:  André Mendes Arent; Luiz Felipe de Souza; Roger Walz; Alcir Luiz Dafre
Journal:  Biomed Res Int       Date:  2014-02-13       Impact factor: 3.411

6.  Protective Effect of N-Acetylcysteine Amide on Blast-Induced Increase in Intracranial Pressure in Rats.

Authors:  Usmah Kawoos; Richard M McCarron; Mikulas Chavko
Journal:  Front Neurol       Date:  2017-06-06       Impact factor: 4.003

Review 7.  Interactions of oxidative stress and neurovascular inflammation in the pathogenesis of traumatic brain injury.

Authors:  P M Abdul-Muneer; Namas Chandra; James Haorah
Journal:  Mol Neurobiol       Date:  2014-05-28       Impact factor: 5.682

Review 8.  Revisiting Traumatic Brain Injury: From Molecular Mechanisms to Therapeutic Interventions.

Authors:  Abbas Jarrahi; Molly Braun; Meenakshi Ahluwalia; Rohan V Gupta; Michael Wilson; Stephanie Munie; Pankaj Ahluwalia; John R Vender; Fernando L Vale; Krishnan M Dhandapani; Kumar Vaibhav
Journal:  Biomedicines       Date:  2020-09-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.